New evaluation of osteoporosis therapies

San Diego, CA (May 15, 2003) -- In a new analysis, gastrointestinal (GI)-related medical expenses for osteoporosis patients initiating therapy with Fosamax® (alendronate sodium tablets) were nearly three times higher than for those patients initiating therapy with Actonel® (risedronate sodium tablets). The data were presented at the annual meeting of the American Association of Clinical Endocrinologists (AACE).

The evaluation assessed the medical costs to managed care organizations for outpatient visits (e.g., hospital outpatient and physician office visits), inpatient care (e.g., hospitalization) and prescriptions for gastro-protective agents, over the first four months of therapy. In this analysis, the average monthly cost for GI-related medical treatment was $2.52 per Actonel patient, compared to $7.40 per Fosamax daily patient and $7.50 per Fosamax weekly patient. Inpatient visits -- typically expensive components in overall medical care -- were 0.2 visits (per 100 patients per month) for Actonel, and 1.2 and 1.6 visits (per 100 patients per month) for Fosamax daily and Fosamax weekly, respectively.

"Extent of inpatient care was the main reason for the difference in GI-related medical costs," said Natalie Borisov, PhD, health economist at P&G Pharmaceuticals, who led the evaluation. "GI-related medical costs are a factor that managed care organizations take into consideration when evaluating the cost profile of an osteoporosis therapy."

Treating patients with a weekly dose of Fosamax versus a daily dose did not markedly change the level of GI-related medical expense or number of inpatient visits that these patients experienced.

Analysis Details
The economic evaluation was conducted with a large medical and pharmaceutical claims database licensed from the health care consulting service, Protocare Sciences. The analysis included 3,947 subjects (93 percent women) age 65 years or older who initiated tr


Page: 1 2 3 4 5

Related medicine news :

1. New evaluation tool reliably predicts recovery from coma
2. Gender bias in child growth evaluations may miss disease in girls
3. The Lancet calls for the creation of a world institute for risk evaluation
4. Women seeking treatment for even minimal male-type hair growth need endocrine evaluation
5. Limitations of current evaluation techniques for the cost-effectiveness of treatments
6. Some chest pain patients may benefit from more evaluation
7. MRI highly useful in the evaluation of patients with uterine fibroids
8. End of life ICU use may require re-evaluation according to University of Pittsburgh study
9. Program evaluation critical to Pakistani doctoral retainment
10. Economic evaluation shows add-on therapy with Keppra(r) is a cost-effective alternative
11. History of broken bones overlooked when treating osteoporosis

Post Your Comments:

(Date:9/3/2020)... ... September 03, 2020 , ... ... has announced the Best Memory Care Facilities in Louisville, KY. The guide identifies ... amenities. , According to the Alzheimer’s Association , 5.6 million people ...
(Date:9/1/2020)... ... , ... KitoTech Medical, a Seattle-based medical device company, announced ... used to accelerate the commercialization of its microMend® family of wound closure products. ... expand its customer base of healthcare systems as well as independent hospitals and ...
(Date:8/31/2020)... ... 2020 , ... Cardiothoracic surgeons at Allegheny General Hospital (AGH), ... University (CMU) to develop a new heart monitoring device designed to serve as ... The AGH/CMU team was recently awarded a “Trailblazer” grant from the National Institutes ...
(Date:8/31/2020)... ... August 31, 2020 , ... Want to get moving, break up your ... Foundation (CPARF) is thrilled to launch its fourth annual STEPtember campaign in the United ... STEPtember meets everyone wherever they are at this moment — encouraging people to move ...
(Date:8/31/2020)... ... ... and topsy-turvy economic outlook continues to put financial strain on many of us, so it ... from our monthly expenses and put more into savings, if possible. , “That’s a great ... safety net in place in case something were to happen to you,” says Lee Duncan, ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... ... September 02, 2020 , ... ... Penetration Technology, LLC, (APT) a Texas- and Indiana-based company ( http://www.aptt3x.com ) ... Counter (OTC) products, was today provided results of an independent laboratory evaluation ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... and Director of Cosmetics and Laser Surgery at the University of Rochester Medical ... Surgery fellowship at SkinCare Physicians in Boston, with clinical faculty from the Harvard ...
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are ... (CDC), About 3% of breast cancers (about 7,500 women per year) and 10% of ... and BRCA2 genes. Both genes are detectable in the Women’s Excellence Genetic Testing ...
Breaking Medicine Technology:
Cached News: